The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2020

Filed:

Jun. 16, 2017
Applicants:

Universite DE Tours, Tours, FR;

Centre Hospitalier Regional Universitaire DE Tours, Tours, FR;

Institut National DE LA Sante ET DE LA Recherche Medicale-inserm, Paris, FR;

Inventors:

Christophe Hourioux, Druye, FR;

Romuald Patient, Joue-les-Tours, FR;

Elodie Beaumont, Ballan-Mire, FR;

Philippe Roingeard, Savonnieres, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/02 (2006.01); A61K 39/29 (2006.01); A61K 39/12 (2006.01); C12N 7/00 (2006.01); C07K 14/005 (2006.01); A61P 31/20 (2006.01); A61P 31/14 (2006.01); C12P 21/02 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/12 (2013.01); A61K 39/292 (2013.01); A61P 31/14 (2018.01); A61P 31/20 (2018.01); C12N 7/00 (2013.01); C12P 21/02 (2013.01); A61K 2039/70 (2013.01); C07K 2319/03 (2013.01); C07K 2319/33 (2013.01); C12N 2730/10134 (2013.01); C12N 2770/24134 (2013.01);
Abstract

An immunogenic fusion protein includes at least the following two peptides a) —on the C-terminal side, a first peptide constituted of: —the amino acid sequence of the protein S or the protein M of a human hepatitis B virus (HBV) isolate, which protein S or protein M is optionally deleted at the N-terminal end thereof, and b) —on the N-terminal side, a second peptide constituted of: —the sequence of amino acids of at least one transmembrane domain and the ectodomain of at least one protein of a Zika virus isolate selected from the envelope protein E or a fusion peptide including the envelope protein E and the protein prM.


Find Patent Forward Citations

Loading…